---
title: "Citi Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285747771.md"
description: "Citi analyst Laura Sutcliffe has maintained a Buy rating on Resmed Inc CHESS Depositary Interests, setting a price target of A$48.00. The shares closed at A$28.82. Sutcliffe, a 3-star analyst with a 53.69% success rate, focuses on the Healthcare sector. The consensus rating for Resmed is a Strong Buy, with an average price target of A$43.13."
datetime: "2026-05-08T14:56:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285747771.md)
  - [en](https://longbridge.com/en/news/285747771.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285747771.md)
---

# Citi Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)

Citi analyst Laura Sutcliffe maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh yesterday and set a price target of A$48.00. The company’s shares closed today at A$28.82.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Sutcliffe is a 3-star analyst with an average return of 2.5% and a 53.69% success rate. Sutcliffe covers the Healthcare sector, focusing on stocks such as Telix Pharmaceuticals, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, and Sonic Healthcare Limited.

Currently, the analyst consensus on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is a Strong Buy with an average price target of A$43.13.

### Related Stocks

- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)
- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)
- [SHL.AU](https://longbridge.com/en/quote/SHL.AU.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP](https://longbridge.com/en/news/286878927.md)
- [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md)
- [Challenger  (CFIGF) Gets a Buy from Ord Minnett](https://longbridge.com/en/news/286831053.md)
- [Bell Potter Sticks to Their Buy Rating for Minerals 260 Limited (MI6)](https://longbridge.com/en/news/286539316.md)
- [Shaw and Partners Keeps Their Buy Rating on Southern Cross Gold Consolidated Ltd. Chees Depository Interest Repr 1 shs (SX2)](https://longbridge.com/en/news/286979340.md)